Filed 1.0y ago· May 31, 2025
16 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Zimmer Biomet
ZBH
$1K-$15K
+13.8% vs S&P 500
Trade dateMay 15, 2025
Common Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–28 of 28
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Zimmer Biomet
ZBH
$1K-$15K
−31.1% vs S&P 500
Trade dateApr 8, 2025
Common Stock
Filed 1.2y ago· Mar 12, 2025
29 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Zimmer Biomet
ZBH
$1K-$15K
+1.7% vs S&P 500
Trade dateFeb 11, 2025
Common Stock
Filed 3.0y ago· Jun 6, 2023
11 days to disclose
Zoe Lofgren
DHouseCalifornia-18
↓sold
UnitedHealth Group
UNH
$1K-$15K
+16.5% vs S&P 500
Trade dateMay 26, 2023
Common Stock (DE)
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Danaher
DHR
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Edwards Lifesciences
EW
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
UnitedHealth Group
UNH
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Common Stock
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Thermo Fisher Scientific
TMO
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
HCA Healthcare
HCA
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
CVS Health
CVS
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Becton Dickinson
BDX
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Becton, Dickinson and Company
Filed 3.4y ago· Dec 26, 2022
28 days to disclose
Nicholas V. Taylor
—HouseTexas-03
↓sold
Zimmer Biomet
ZBH
$100K-$250K
+9.1% vs S&P 500
Trade dateNov 28, 2022
Filed 3.6y ago· Oct 11, 2022
32 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Becton Dickinson
BDX
$1K-$15K
−43.8% vs S&P 500
Trade dateSep 9, 2022
Becton, Dickinson and Company
Filed 3.7y ago· Sep 13, 2022
19 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Charles River Laboratories International
CRL
$1K-$15K
+13.4% vs S&P 500
Trade dateAug 25, 2022
International
Filed 3.8y ago· Aug 31, 2022
34 days to disclose
Lois Frankel
DHouseFlorida-22
↓sold
Zimmer Biomet
ZBH
$1K-$15K
+11.8% vs S&P 500
Trade dateJul 28, 2022
Filed 3.8y ago· Aug 13, 2022
317 days to disclose · 272 past 45-day window
Susie Lee
DHouseNevada-03
↓sold
Zimmer Biomet
ZBH
$15K-$50K
+66.3% vs S&P 500
Trade dateSep 30, 2021
Filed 4.0y ago· Jun 16, 2022
3 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Zimmer Biomet
ZBH
$1K-$15K
+22.0% vs S&P 500
Trade dateJun 13, 2022
Filed 4.7y ago· Oct 7, 2021
7 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Charles River Laboratories International
CRL
$1K-$15K
−72.6% vs S&P 500
Trade dateSep 30, 2021
International
Filed 4.7y ago· Oct 7, 2021
35 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Thermo Fisher Scientific
TMO
$1K-$15K
−25.0% vs S&P 500
Trade dateSep 2, 2021
Filed 4.7y ago· Oct 7, 2021
35 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Danaher
DHR
$1K-$15K
−47.6% vs S&P 500
Trade dateSep 2, 2021
Filed 4.7y ago· Oct 7, 2021
35 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Edwards Lifesciences
EW
$1K-$15K
−39.0% vs S&P 500
Trade dateSep 2, 2021
Filed 4.7y ago· Oct 7, 2021
35 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
HCA Healthcare
HCA
$1K-$15K
+60.9% vs S&P 500
Trade dateSep 2, 2021
Filed 4.7y ago· Sep 10, 2021
17 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
CVS Health
CVS
$1K-$15K
+9.5% vs S&P 500
Trade dateAug 24, 2021
Filed 4.7y ago· Sep 10, 2021
32 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
HCA Healthcare
HCA
$1K-$15K
+61.4% vs S&P 500
Trade dateAug 9, 2021
Filed 4.7y ago· Sep 10, 2021
32 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Edwards Lifesciences
EW
$1K-$15K
−37.8% vs S&P 500
Trade dateAug 9, 2021
Filed 4.7y ago· Sep 10, 2021
32 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Thermo Fisher Scientific
TMO
$1K-$15K
−24.5% vs S&P 500
Trade dateAug 9, 2021
Filed 4.7y ago· Sep 10, 2021
32 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
UnitedHealth Group
UNH
$1K-$15K
Trade dateAug 9, 2021
Filed 4.9y ago· Jul 13, 2021
15 days to discloseSusie Lee
DHouseNevada-03
↑bought
Zimmer Biomet
ZBH
$1K-$15K
−108.4% vs S&P 500
Trade dateJun 28, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 31, 2025 1.0y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Zimmer Biomet ZBH Common Stock | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Zimmer Biomet ZBH Common Stock | Apr 8, 2025 30 days to disclose | Bad buy·−$1.6K-19.4% −31.1% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | Julie Johnson DHouseTexas-32 | ↓sold | Zimmer Biomet ZBH Common Stock | Feb 11, 2025 29 days to disclose | Flat·+0.0% +1.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | UnitedHealth Group UNH Common Stock (DE) | May 26, 2023 11 days to disclose | Flat·+0.0% +16.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Danaher DHR | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Edwards Lifesciences EW | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | UnitedHealth Group UNH Common Stock | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Thermo Fisher Scientific TMO | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | HCA Healthcare HCA | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | CVS Health CVS | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Becton Dickinson BDX Becton, Dickinson and Company | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 26, 2022 3.4y ago | Nicholas V. Taylor —HouseTexas-03 | ↓sold | Zimmer Biomet ZBH | Nov 28, 2022 28 days to disclose | Flat·+0.0% +9.1% vs S&P 500 | $100K-$250K midpoint $175K |
Oct 11, 2022 3.6y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Becton Dickinson BDX Becton, Dickinson and Company | Sep 9, 2022 32 days to disclose | Bad buy·−$2.4K-30.0% −43.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 13, 2022 3.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Charles River Laboratories International CRL International | Aug 25, 2022 19 days to disclose | Flat·+0.0% +13.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 31, 2022 3.8y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Zimmer Biomet ZBH | Jul 28, 2022 34 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2022 3.8y ago | Susie Lee DHouseNevada-03 | ↓sold | Zimmer Biomet ZBH | Sep 30, 2021 317 days to disclose · 272 past 45-day window | Flat·+0.0% +66.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 16, 2022 4.0y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Zimmer Biomet ZBH | Jun 13, 2022 3 days to disclose | Flat·+0.0% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Charles River Laboratories International CRL International | Sep 30, 2021 7 days to disclose | Bad buy·−$4.5K-56.0% −72.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Thermo Fisher Scientific TMO | Sep 2, 2021 35 days to disclose | Bad buy·−$1.3K-16.4% −25.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Danaher DHR | Sep 2, 2021 35 days to disclose | Bad buy·−$3.1K-38.9% −47.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Edwards Lifesciences EW | Sep 2, 2021 35 days to disclose | Bad buy·−$2.4K-30.4% −39.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | HCA Healthcare HCA | Sep 2, 2021 35 days to disclose | Good buy·+$5.6K+69.6% +60.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | CVS Health CVS | Aug 24, 2021 17 days to disclose | Flat·+0.0% +9.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | HCA Healthcare HCA | Aug 9, 2021 32 days to disclose | Good buy·+$5.8K+72.7% +61.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Edwards Lifesciences EW | Aug 9, 2021 32 days to disclose | Bad buy·−$2.1K-26.5% −37.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Thermo Fisher Scientific TMO | Aug 9, 2021 32 days to disclose | Bad buy·−$1.1K-13.2% −24.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | UnitedHealth Group UNH | Aug 9, 2021 32 days to disclose | price pending | $1K-$15K midpoint $8K |
Jul 13, 2021 4.9y ago | Susie Lee DHouseNevada-03 | ↑bought | Zimmer Biomet ZBH | Jun 28, 2021 15 days to disclose | Bad buy·−$3.3K-41.4% −108.4% vs S&P 500 | $1K-$15K midpoint $8K |